Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety
Articolo
Data di Pubblicazione:
2019
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Kristeleit, Rs; Oaknin, A; Ray-Coquard, I; Leary, A; Balmaña, J; Drew, Y; Oza, Am; Shapira-Frommer, R; Domchek, Sm; Cameron, T; Maloney, L; Goble, S; Lorusso, D; Ledermann, Ja; Mcneish, Ia.
Link alla scheda completa:
Pubblicato in: